Gastric Cancer- Continuous Forecasting and Advisory Service – 12 Month Subscription

Pages: 350 Published: April 01, 2011 Report Code: GDHC005CFAS

  • Overview
  • Contents
  • Tables
  • Figures
  • Listen
    iSpeech

A 12 month subscription to our “Gastric Cancer – Continuous Forecasting and Advisory Service” provides clients with a comprehensive study of the gastric cancer market with forecasting until 2020. At the heart of the Continuous Forecasting and Advisory Service” is a 350+ page report that analyses the gastric cancer therapeutics market in the US, the UK, France, Germany, Spain, Italy and Japan and the emerging countries of Brazil, Russia, India, and China with detailed market forecasts up to 2020. As a subscriber to the service you will also receive supporting drug sales and patient volume models in excel format, a PowerPoint presentation pack, a 2 hour personalized interactive webinar with GlobalData’s Oncology Analysis Team, Access to GlobalData’s Continuous Forecasting and Advisory Service, Quarterly updates of the gastric cancer report, PPT presentation pack and drug sales and patient volume models. You will also have access to our analysts; on hand to support you and answer any questions you may have.

Scope

350+ page report providing an in-depth analysis of the gastric cancer market

Data forecasts until 2020 covering 11 countries worldwide

Geographical coverage – analysis of the US, UK, Germany, France, Italy, Spain and Japan, as well as emerging countries such as Brazil, Russia, India and China

Drug sales for gastric cancer until 2020, including forecasted drug sales for pipeline products

Treatment usage pattern including treatment seeking, diagnosis and prescription population

Strategic assessment of the pipeline and current products backed by detailed data

Assessment of recent events and their effects on the market landscape

Direct quotes from 70 key opinion leader (KOL) physicians per report across 11 countries

Supporting drug sales and patient volume models in excel format

PowerPoint presentation pack

2 hour personalized interactive webinar with GlobalData’s Oncology Analysis Team

Access to GlobalData’s Continuous Forecasting and Advisory Service

Quarterly updates of the gastric cancer report, PPT presentation pack and drug sales and patient volume models

Analysts on hand to support you and answer any questions you may have

Reasons to Buy

Track and forecast drug sales by country from 2002 to 2020

Quantify and assess unmet needs in the gastric cancermarket

Monitor the deals and licensing landscape

Understand pricing and reimbursement methodologies across countries

Perform market sizing, forecasts and quantified growth opportunities in the market till 2020

Understand diseases opportunities in emerging countries such as Brazil, Russia, India and China

Quantify patient population in all countries to better design product pricing & launch plans

Perform benchmarking analysis and growth opportunities against currently marketed products

Identify market entry points based on safety, efficacy, and pricing parameters

Assess competitiveness of products in the market by understanding the strength and weakness of the current competition

Assess strength of pipeline bases on first in class, me-too, generic and lifecycle management of products

Perform clinical trials and pipeline analysis to keep up to date with latest environmental changes

Table of Contents

N/A

List of Tables

N/A

List of Figures

N/A

$15000

Can be used by individual purchaser only

$45000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.